BIOCERAM AZUL® by Kyocera: Innovation and strategy in the spotlight at DKOU 2024
Rethinking medical technology – Kyocera embraces future-ready solutions.
- Fine Ceramic Components
Kyoto/Esslingen − KYOCERA Fineceramics Medical GmbH (KFMG) showcased its innovative ceramic solution, BIOCERAM AZUL®, for hip endoprostheses at DKOU 2024, held in Berlin from October 22 to 25. A highlight of the event was the lunch symposium on October 23, where industry representatives, surgeons, and materials scientists gained deep insights into the material and clinical properties of BIOCERAM AZUL®.
BIOCERAM AZUL® – an innovative material for hip prostheses
Already a success in Japan, Kyocera impressed attendees at DKOU with BIOCERAM AZUL® in its European debut. Known for its high fracture toughness and excellent biocompatibility, the material offers a pioneering solution in hip endoprosthetics. During the lunch symposium, Dr. Fabian Preuß, Prof. Michael Morlock, Dr. Taro Umezu, and Prof. Stelter discussed the material’s benefits and clinical performance. Moderated by Prof. Dieter Wirtz, the session provided a comprehensive outlook on the future of medical ceramic technology.
Kyocera’s long-term strategy in medical technology
Dr. Fabian Preuß, Managing Director of KYOCERA Fineceramics Medical GmbH, presented the company’s long-term strategy, emphasizing future growth: “Our goal is to enter the market as a strategic supplier of ceramic femoral heads for hip prostheses, providing reliable solutions to our customers. In the second phase, we aim to position ourselves as a strategic partner for all types of medical ceramic solutions within the human body, ultimately becoming the leading company in medical ceramics.”
Kyocera’s commitment to the European market
Kyocera’s presence at DKOU 2024 represents a significant milestone for the company and highlights its commitment to the European medical technology market. In addition to BIOCERAM AZUL®, KFMG is planning to expand its product portfolio, supported by a new production facility in Waiblingen, which is set to open in 2025. This facility will manufacture high-quality medical ceramic products for the global market, addressing the growing demand for biocompatible and durable solutions.
About DKOU 2024
The DKOU is the largest European congress for orthopedics and trauma surgery, providing a central platform for sharing the latest technological and clinical developments.
